Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.95 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.95 |
| ▸ | MAPT | P10636 | 2/20 | 0.95 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.36 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.35 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.32 |
| ▸ | ENPEP | Q07075 | 3/20 | 0.32 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.31 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.31 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.30 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Penicillamine SCHEMBL9195712 | 1.00 | ALDH1A1 (0.95) | ALDH1A1PTGS1MAPTSLC7A5SLC7A11 | |
| Dl-Penicillamine SCHEMBL28222280 | 1.00 | ALDH1A1 (0.95) | ALDH1A1PTGS1MAPTSLC7A5SLC7A11 | |
| Penicillamine SCHEMBL8509793 | 1.00 | ALDH1A1 (0.95) | ALDH1A1PTGS1MAPTSLC7A5SLC7A11 | |
| Penicillamine SCHEMBL4911772 | 1.00 | ALDH1A1 (0.95) | ALDH1A1PTGS1MAPTSLC7A5SLC7A11 | |
| Penicillamine SCHEMBL4343 | 0.97 | — | — | |
| Dl-Penicillamine SCHEMBL57527 | 0.97 | — | — | |
| Dl-Penicillamine SCHEMBL4344 | 0.97 | — | — | |
| Dl-Penicillamine SCHEMBL22322162 | 0.97 | ALDH1A1 (1.00) | ALDH1A1PTGS1MAPTSLC7A5SLC7A11 | |
| Penicillamine SCHEMBL129296 | 0.97 | ALDH1A1 (1.00) | ALDH1A1PTGS1MAPTSLC7A5SLC7A11 | |
| Dl-Penicillamine SCHEMBL159653 | 0.97 | ALDH1A1 (1.00) | ALDH1A1PTGS1MAPTSLC7A5SLC7A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12098391-B2 | Generation of hepatocytes from pluripotent stem cells | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2024-09-24 | — | — | US | claimed |
| CN-109072438-B | Methods of depositing a metal or metal alloy onto a substrate surface and including substrate surface activation | 德国艾托特克公司 | 2021-08-13 | — | — | CN | claimed |
| US-10287552-B2 | Generation of hepatocytes from pluripotent stem cells | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2019-05-14 | — | — | US | claimed |
| WO-2014004784-A1 | GENERATION OF HEPATOCYTES FROM PLURIPOTENT STEM CELLS | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2014-01-03 | — | — | WO | claimed |
| EP-0397437-A1 | Method of treating human eyes and a composition thereof | PILKINGTON VISIONCARE HOLDINGS, INC. (US) | 1990-11-14 | — | — | EP | claimed |
| JP-3027314-A | — | — | None | — | — | JP | disclosed |
| CN-118851961-B | Process method for synthesizing D-penicillamine | 中科全同(大连)医药科技有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-118851961-A | Process method for synthesizing D-penicillamine | 中科全同(大连)医药科技有限公司 | 2024-10-29 | — | — | CN | disclosed |
| US-12098391-B2 | Generation of hepatocytes from pluripotent stem cells | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2024-09-24 | — | — | US | disclosed |
| US-20220304923-A1 | USE OF ORAL CHEW FOR MODULATING ORAL MICROBIOTA AND IMPROVING ORAL HEALTH | MARS, INCORPORATED (US) | 2022-09-29 | — | — | US | disclosed |
| US-20220304335-A1 | MODULATION OF ORAL MICROBIOTA | MARS, INCORPORATED (US) | 2022-09-29 | — | — | US | disclosed |
| EP-3979813-A1 | MODULATION OF ORAL MICROBIOTA | Mars Incorporated (US) | 2022-04-13 | — | — | EP | disclosed |
| WO-1998006435-A2 | COMPOSITIONS OF ANTICHLAMYDIAL AGENTS FOR THE DIAGNOSIS AND MANAGEMENT OF INFECTION CAUSED BY $i(CHLAMYDIA) | VANDERBILT UNIVERSITY (US) | 1998-02-19 | — | — | WO | disclosed |
| EP-0675712-A4 | REDUCTION OF HAIR GROWTH EMPLOYING SULFHYDRYL REACTIVE COMPOUNDS. | HANDELMAN JOSEPH H (US) | 1996-11-06 | — | — | EP | disclosed |
| EP-0675712-A1 | REDUCTION OF HAIR GROWTH EMPLOYING SULFHYDRYL REACTIVE COMPOUNDS | HANDELMAN, Joseph H. (US) | 1995-10-11 | — | — | EP | disclosed |
| US-5411991-A | Applying to human skin, beards, reaction with cysteine | GILLETTE COMPANY, THE, A DELAWARE CORPORATION | 1995-05-02 | — | — | US | disclosed |
| WO-1994014428-A1 | REDUCTION OF HAIR GROWTH EMPLOYING SULFHYDRYL REACTIVE COMPOUNDS | HANDELMAN, JOSEPH, H. (US) | 1994-07-07 | — | — | WO | disclosed |
| JP-H0327314-A | COMPOSITION FOR TREATING HUMAN EYE | PILKINGTON VISIONCARE INC | 1991-02-05 | — | — | JP | disclosed |
| EP-0397437-A1 | Method of treating human eyes and a composition thereof | PILKINGTON VISIONCARE HOLDINGS, INC. (US) | 1990-11-14 | — | — | EP | disclosed |
| EP-0397437-A1 | Method of treating human eyes and a composition thereof | PILKINGTON VISIONCARE HOLDINGS, INC. (US) | 1990-11-14 | — | — | EP | disclosed |